Endo's $82.5M Deal In Suit Over Opioid Drug Gets Final OK
An $82.5 million cash deal ending investors' claims that pharmaceutical company Endo International PLC hid safety issues with an opioid drug was finalized in Pennsylvania federal court Friday....To view the full article, register now.
Already a subscriber? Click here to view full article